Asthma, allergy, and IgE levels in NYC head start children

Demetra Z Rotsides1, Inge F Goldstein, Stephen M Canfield

  • 1Department of Epidemiology, Mailman School of Public Health, Columbia University, NY 10032, New York, United States.

Respiratory Medicine
|November 17, 2009
PubMed

Insights

Pediatric asthma in NYC is linked to total immunoglobulin E (IgE) and indoor allergens like dust mites. Allergy symptoms showed a stronger association with asthma than specific IgE levels.

Area of Science:

  • Pediatric Allergy and Immunology
  • Environmental Health
  • Respiratory Medicine

Background:

  • Investigated asthma associations in preschool children from high-asthma hospitalization neighborhoods in New York City.
  • Focused on total immunoglobulin E (IgE), specific IgE to indoor allergens, and allergy symptoms.

Purpose of the Study:

  • To analyze the relationship between total IgE, specific IgE to common indoor allergens, allergy symptoms, and asthma in urban preschool children.
  • To identify risk factors for asthma in a vulnerable urban pediatric population.

Main Methods:

  • Surveyed parents of children in New York City Head Start programs regarding demographics, health, lifestyle, and home environment.
  • Measured total and specific IgE (to cockroach, dust mite, mouse, cat) in children's serum.
  • Employed multivariable logistic regression to model asthma association with IgE and allergy symptoms, controlling for covariates.

Main Results:

  • 33% of 453 preschool children had asthma.
  • Asthma was associated with sensitization to any of the four indoor allergens (OR=1.6) and the highest quartile of total IgE (OR=3.1).
  • Allergy symptoms were independently and strongly associated with asthma (OR=3.7).

Conclusions:

  • Asthma in urban preschoolers is linked to total IgE and sensitization to common indoor allergens.
  • Allergy symptoms were more prevalent and strongly associated with asthma than specific IgE sensitization.
  • Allergy symptoms may precede elevated specific IgE or indicate alternative asthma pathways.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Reactions02:06

Allergic Reactions

Overview
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes: